Imaging brain tumors with ferumoxtran-10, a nanoparticle magnetic resonance contrast agent

Author： Murillo Tulio P   Sandquist Chloe   Jacobs Paula M   Nesbit Gary   Manninger Sandor   Neuwelt Edward A  

Publisher： Future Medicine

ISSN： 1475-0708

Source： Therapy, Vol.2, Iss.6, 2005-11, pp. : 871-882

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Role of Dynamic Contrast-Enhanced Perfusion Magnetic Resonance Imaging in Grading of Pediatric Brain Tumors on 3T

By  

Pediatric Neurosurgery, Vol. 52, Iss. 5, 2017-08 ,pp. : 298-305

Karger

Access to resources Recommend Favorite

Gold nanoparticle imaging and radiotherapy of brain tumors in mice

By Hainfeld James F   Smilowitz Henry M   O’Connor Michael J   Dilmanian Farrokh Avraham   Slatkin Daniel N  

Nanomedicine, Vol. 8, Iss. 10, 2013-10 ,pp. : 1601-1609

Future Medicine

Access to resources Recommend Favorite

Quantitative myocardial perfusion magnetic resonance imaging: the impact of pulsatile flow on contrast agent bolus dispersion

By Graafen Dirk   Hamer Julia   Weber Stefan   Schreiber Laura M  

Physics in Medicine and Biology, Vol. 56, Iss. 16, 2011-08 ,pp. : 5167-5185

IOP Publishing

Access to resources Recommend Favorite

In vitro assessment of the dual-targeting behavior of a peptide-based magnetic resonance imaging contrast agent

By          

International Journal of Molecular Medicine, Vol. 33, Iss. 1, 2014-01 ,pp. : 215-220

Spandidos Publications

Access to resources Recommend Favorite

Neurosyphilis and brain magnetic resonance imaging

By  

INTERNATIONAL JOURNAL OF DERMATOLOGY, Vol. 54, Iss. 7, 2015-07 ,pp. : 863-863

John Wiley & Sons Inc

Access to resources Recommend Favorite